Jafron Biomedical Co.,Ltd. (SHE:300529)
China flag China · Delayed Price · Currency is CNY
19.75
+0.02 (0.10%)
At close: Dec 12, 2025

Jafron Biomedical Company Description

Jafron Biomedical Co.,Ltd. engages in the research and development, production, and sale of blood purification products for hemadsorption field worldwide.

The company offers therapies for kidney, liver, and critical diseases, as well as poisoning. It also provides HA series disposable hemoperfusion cartridge; BS series disposable plasma bilirubin perfusion adsorption column; blood purification machine; and other products, such as JM hemodialyzer, DNA230, disinfectant, hemodialysis concentrate, resin bandage, online hemodialysis B powder bag/bucket, PGA absorbable suture with needle, syringe and infusion pumps.

The company was founded in 1989 and is based in Zhuhai, China.

Jafron Biomedical Co.,Ltd.
CountryChina
Founded1989
IndustryMedical Devices
SectorHealthcare
Employees2,797
CEOFan Dong

Contact Details

Address:
No. 98 Technology Six Road
Zhuhai, 519085
China
Phone86 75 6368 9708
Websitejafroninternational.com

Stock Details

Ticker Symbol300529
ExchangeShenzhen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE100002995
SIC Code3842

Key Executives

NamePosition
Fan DongChairman of Board of Directors and GM
Xueyun LiaoDirector and Financial Director
De Zhi LiDeputy General Manager
Xian Min TangDeputy GM and Director
Feng LiDeputy GM and Non-Independent Director
Aijun WuDeputy General Manager
Rui WangGeneral Manager
Cong HuangBoard Secretary